Glucose monitoring

The U.S. market for dmgs to control blood glucose totals about 1 x 10 , equally divided between insulin and all other antidiabetic dmgs (33). Insulin sales ate expected to grow by about 10% annually, whereas the antidiabetic dmg market as a whole is expected to shrink by about 3%. The blood glucose monitoring market totals about 7.5 x 10 in the United States and is expected to grow at a rate of 10% annually. 

Urine testing has been widely used to monitor glucose levels in die past, but this metiiod has largely been replaced witii blood glucose monitoring. 

Carefully follow manufacturer s instructions because blood glucose monitoring devices vary greatly. 

Possibilities for Enzymes in Implantable Fuel Cells There is significant and increasing demand for power supplies for implantable medical devices, including continuous glucose monitors for diabetic patients, thermal sensors for... 

Okuda J, Yamazaki T, Fukasawa M, Kakehi N, Sode K. 2007. The application of engineered glucose dehydrogenase to a direct electron-transfer-type continuous glucose monitoring system and a compartmentless biofuel cell. Anal Lett 40 431 -440. 

PTSD Posttraumatic stress disorder SBGM Self blood glucose monitoring... 

Other forms of analytical investigations may also be applied, such as at-line analysis (discontinuous direct analysis of objects, e.g., noninvasive blood glucose monitoring) and trans-line analysis (remote sensing, teleanalysis). 

Fischbacher C, Jagemann K-U, Danzer K, MUller UA, Mertes B (1995) Non-invasive blood glucose monitoring by chemometrical evaluation ofNIR-spectra. 24th EAS (Eastern Analytical Symposium), Somerset, NJ, November 12-16... 

Danzer K, Fischbacher C, Jagemann K-U, Reichelt KJ (1998) Near-infrared diffuse reflection spectroscopy for non-invasive blood-glucose monitoring. LEOS Newslett 12(2) 9... 

A thiol-reactive squaraine 36 (iodoacetamide) that displays fluorescence emission above 650 nm was used to develop a reagentless glucose monitoring assay [102]. 

The ideal glucose monitoring system should be non invasive, should allow continuous or frequent monitoring over long periods without the need to replace the changeable parts (strip, transdermal patch, etc.), should interfere minimally with daily life, and, last but not least, should be low in cost. 

Klonoff D.C., Noninvasive blood glucose monitoring, Diabetes Care 1997 20 (3) 433-437. 

Introduction of a wearable non-invasive glucose monitor Cygness Inc. 

G. Reach and G.S. Wilson, Can continuous glucose monitoring be used for the treatment of diabetes Anal. Chem. 64, 381A-389A (1992). 

T.M. Gross, Efficacy and reliability of the continuous glucose monitoring system. Diabetes Technol. Ther. 2, S19-S26 (2000). 

Clinical utility takes the concept a step further and shows that the patient s medical outcome is favorably influenced by knowledge of the diagnostic test. An example would be that the tight insulin control that is only possible with frequent home blood glucose monitoring has a positive impact on delay of complications of diabetes. FDA does not require that a demonstration of clinical utility be performed in support of submissions but does... 

Bolinder J, Ungerstedt U, Amer P. 1993. Long-term continuous glucose monitoring with microdialysis in ambulatory insulin-dependent diabetic patients. Lancet 342(8879) 1080-1085. 

Q58 In d iabetes, blood glucose monitoring by the patient is of benefit ... 

Q87 Urinalysis for glucose monitoring is a good indicator of hypogly-caemia or hyperglycaemia. Blood glucose concentrations should be maintained at a constant level. 

---